Together with Consulting Editor Dr. Helen Boucher, Drs. Watkins and Bonomo have put together an issue of Infectious Disease Clinics of North America that provides the most current information on antibiotic resistance. Top experts have contributed clinical review articles that address the types of resistance based on drug class as well as emerging therapies and the future of telemedicine in the management of infections. The following topics are covered in this issue: The changing role of the clinical microbiology laboratory in defining resistance in gram-negatives; Extended-spectrum β-lactamase-producing Enterobacteriaceae infections; Multidrug-resistant bacteria in the community; Resistance to polymyxins; Resistance in Vancomycin-resistant enterococci; Resistance to newer β-lactamase inhibitors; Antibiotic-resistant infections in the immunocompromised host; Emerging therapies for MRSA infections; Drug-resistant tuberculosis; Aminoglycoside resistance; The role of antibiotic stewardship and telemedicine in the management of MDR infections; and Emerging issues in antifungal resistance. Readers will have the current information they need to better manage antibiotic-resistant infections in patients.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Overview: The Ongoing Threat of Antimicrobial Resistance - p. 649 9. The Evolving Role of the Clinical Microbiology Laboratory in Identifying Resistance in Gram-Negative Bacteria: An Update - p. 659 10. The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections: An Update - p. 677 11. Multidrug-Resistant Bacteria in the Community: An Update - p. 709 12. Agents of Last Resort: An Update on Polymyxin Resistance - p. 723 13. Resistance in Vancomycin-Resistant Enterococci - p. 751 14. Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations: The “Price of Progress” - p. 773 15. Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host: An Update - p. 821 16. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches - p. 849 17. Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges - p. 863 18. Aminoglycoside Resistance: Updates with a Focus on Acquired 16S Ribosomal RNA Methyltransferases - p. 887 19. The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections - p. 903 20. Emerging Issues in Antifungal Resistance - p. 921
Together with Consulting Editor Dr. Helen Boucher, Drs. Watkins and Bonomo have put together an issue of Infectious Disease Clinics of North America that provides the most current information on antibiotic resistance. Top experts have contributed clinical review articles that address the types of resistance based on drug class as well as emerging therapies and the future of telemedicine in the management of infections. The following topics are covered in this issue: The changing role of the clinical microbiology laboratory in defining resistance in gram-negatives; Extended-spectrum β-lactamase-producing Enterobacteriaceae infections; Multidrug-resistant bacteria in the community; Resistance to polymyxins; Resistance in Vancomycin-resistant enterococci; Resistance to newer β-lactamase inhibitors; Antibiotic-resistant infections in the immunocompromised host; Emerging therapies for MRSA infections; Drug-resistant tuberculosis; Aminoglycoside resistance; The role of antibiotic stewardship and telemedicine in the management of MDR infections; and Emerging issues in antifungal resistance. Readers will have the current information they need to better manage antibiotic-resistant infections in patients.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Overview: The Ongoing Threat of Antimicrobial Resistance - p. 649 9. The Evolving Role of the Clinical Microbiology Laboratory in Identifying Resistance in Gram-Negative Bacteria: An Update - p. 659 10. The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections: An Update - p. 677 11. Multidrug-Resistant Bacteria in the Community: An Update - p. 709 12. Agents of Last Resort: An Update on Polymyxin Resistance - p. 723 13. Resistance in Vancomycin-Resistant Enterococci - p. 751 14. Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations: The “Price of Progress” - p. 773 15. Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host: An Update - p. 821 16. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches - p. 849 17. Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges - p. 863 18. Aminoglycoside Resistance: Updates with a Focus on Acquired 16S Ribosomal RNA Methyltransferases - p. 887 19. The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections - p. 903 20. Emerging Issues in Antifungal Resistance - p. 921
